DrugDatabase
Search FDA drug approvals, recalls, and adverse events. Real data from the openFDA API.
Latest Recalls
Presence of Foreign Tablets/Capsules
Advagen Pharma LimitedCGMP Deviations
Fei Fah Medical Manufacturing Pte. Ltd.Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories
American Health PackagingPresence of Foreign Tablets/Capsules
MSN Laboratories Private Limited (Formulations Division, Unit-II)CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Hikma Pharmaceuticals USA INC.CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Hikma Pharmaceuticals USA INC.Lack of Processing Controls
Victory Medical Center PharmacyLack of Processing Controls
Victory Medical Center PharmacyRecent Approvals
Original approvals (new applications, including generics) granted in the last 12 months, from Drugs@FDA.
Quick Stats
About this data
Everything on DrugDatabase comes from the openFDA API run by the U.S. Food and Drug Administration. Drug pages combine three openFDA datasets: Drugs@FDA (approved applications, sponsor, route and active substance), drug enforcement reports (recalls, with Class I being the most serious) and FAERS, the adverse event reporting system. The FDA refreshes enforcement reports weekly and FAERS quarterly; this site caches responses for up to an hour.
Start with a drug search by brand or generic name, browse the latest recalls by class, or look up the most reported reactions for a drug. Adverse event counts are reports, not proven side effects, and nothing here is medical advice.
Latest Blog

A drug label is a living document, and the live FDA data on this site shows it moving. Safety warnings get added as adverse event ...

Recalls rarely make the evening news, yet the live FDA enforcement feed on this site records them week after week. Class I actions...

A new medicine does not simply face competition the day after approval. Patents and FDA exclusivity periods decide when generic ma...